# STAT
*Canonical page:* https://truthscore.com/entity/stat--386551b8
*Machine twins:* https://truthscore.com/entity/stat--386551b8.md · JSON at https://truthscore.com/api/v1

Kind: **org**

## Statements attributed to it

- [FDA staff said their review of research found insufficient evidence to support semax’s use for the conditions in question.](https://truthscore.com/claim/07998ac3) — independent
- [The FDA advisory panel recommended that compounding pharmacies be allowed to manufacture the peptides epitalon and semax, and recommended against manufacturing…](https://truthscore.com/claim/0e8e0a83) — independent
- [On Friday, the panel voted 7-4 to add epitalon to the list for insomnia.](https://truthscore.com/claim/20eda73b) — independent
- [Peptides have become increasingly popular in the United States, driven by endorsements from social media influencers.](https://truthscore.com/claim/253210d2) — independent
- [The administration will publish its decision as a proposed rule and give the public the opportunity to comment.](https://truthscore.com/claim/85598dda) — independent
- [The vote on adding semax for migraines and neurological conditions was 8-5.](https://truthscore.com/claim/8b489c37) — independent
- [On Thursday, the panel voted 8-6 to add BPC-157 to the list for treating ulcerative colitis, to add KPV for wound healing and inflammatory conditions, and to…](https://truthscore.com/claim/a4b18581) — independent
- [Vociferous supporters of semax noted that there is more data on the drug because it is approved in Russia for clinical use.](https://truthscore.com/claim/a8369771) — independent
- [It is possible that Robert F. Kennedy Jr. or Kyle Diamantas could overrule career employees.](https://truthscore.com/claim/b6f0b4fd) — independent
- [Emideltide failed voting passage by a tally of 6-7.](https://truthscore.com/claim/c22345d1) — independent
- [The panel’s decision on Thursday recommended allowing pharmacies to make four other peptides.](https://truthscore.com/claim/c94d40e2) — independent
- [The panel’s decision brings Robert F. Kennedy Jr. one step closer to his mission of making these unapproved compounds more available for Americans.](https://truthscore.com/claim/d98e2122) — independent
- [Panelists who voted yes said they did not have to consider the lack of robust clinical data.](https://truthscore.com/claim/dbf95f57) — independent
- [The agency has no authority to require compounders to submit safety or efficacy data once a substance is added to the list.](https://truthscore.com/claim/ddc82a13) — independent
- [The article has been updated to add the vote on semax.](https://truthscore.com/claim/e47edb29) — independent
- [The panel voted 7-5 to add MOTS-c to the list for obesity and osteoporosis.](https://truthscore.com/claim/e667168a) — independent
- [FDA staff told the panelists they recommended against giving compounders the green light due to a lack of clinical evidence demonstrating safety and efficacy.](https://truthscore.com/claim/ea295a13) — independent
- [FDA experts repeatedly stressed that adding the peptides to the section 503A bulk drug substances list would be a dangerous experiment, with physicians flying…](https://truthscore.com/claim/ebfd0090) — independent
- [Several panelists wanted to satisfy their individual patients who have been clamoring for these substances.](https://truthscore.com/claim/f761f7ff) — independent
- [The fundamental question facing panelists was whether it is acceptable to let individuals take medicines of unclear safety or efficacy.](https://truthscore.com/claim/fc7e0151) — independent

## Published documents

- [FDA advisory panel narrowly rejects compounding of one peptide, backs two others](https://truthscore.com/source/a99385d6)

**Track record** (counts, not a rating): 1 document · 24 claims produced · 0 contradicted.